{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-004925","form_type":"8-K","ticker":"ALEC","cik":"0001653087","company_name":"Alector, Inc.","filed_at":"2022-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.632314+00:00","generated_at":"2026-06-26T14:52:18.113724+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Alector appoints Gary Romano, M.D., Ph.D., as CMO effective May 23, 2022","bullets":["Appointed Gary Romano, M.D., Ph.D., as Chief Medical Officer, effective May 23, 2022.","Annual base salary of $475,000; eligible for performance bonus of 40%; equity awards: $3.9M stock option (4-yr vest) and $975K RSU (3-yr vest).","He brings over 25 years of neurodegenerative disease experience, previously CMO at Passage Bio and roles at Janssen and Merck.","Interim CMO Sam Jackson, M.D., M.B.A., is leaving Alector to pursue a new opportunity; will continue as a consultant.","He will report to President and Head of R&D Sara Kenkare-Mitra."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-004925","json":"https://secwatch.observer/filing/0000950170-22-004925.json","markdown":"https://secwatch.observer/filing/0000950170-22-004925.md","text":"https://secwatch.observer/filing/0000950170-22-004925.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022004925/0000950170-22-004925-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022004925/alec-20220329.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T14:52:18.113724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5feec8d4dd","claim":"Gary Romano, Ph.D., M.D. was appointed as Chief Medical Officer at Alector, Inc..","evidence_excerpt":"On March 29, 2022, Alector, Inc. (“Alector”) announced the appointment of Gary Romano, Ph.D., M.D., as Alector’s Chief Medical Officer , effective May 23, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022004925/0000950170-22-004925-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}